Acne Treatment Patent EP3458079A1, University of California, Apr 15 2026
Summary
The European Patent Office published patent application EP3458079A1 titled 'Compositions and Methods for Treating Acne' on April 15, 2026. The applicants are the Regents of the University of California and the University of Pittsburgh of the Commonwealth System of Higher Education. The listed inventors include MODLIN, Robert L., MILLER, Jeffery F., MARINELLI, Laura J., and HATFULL, Graham F., with IPC classifications covering viral vectors (A61K 35/76) and acne treatment applications (A61P 17/10).
About this source
GovPing monitors EPO Patent Bulletin - Therapeutics (A61P) for new healthcare & life sciences regulatory changes. Every update since tracking began is archived, classified, and available as free RSS or email alerts — 17 changes logged to date.
What changed
The EPO published patent application EP3458079A1 for compositions and methods treating acne, filed jointly by the Regents of the University of California and the University of Pittsburgh. The application covers viral vector technologies under IPC classifications A61K 35/76 and A61P 17/10, designating 35 European states including AT, BE, DE, ES, FR, GB, IT, NL, and PL.
Parties conducting research in dermatological therapeutics or viral vector delivery systems should review the published claims for potential freedom-to-operate implications. Competitors developing acne treatments may wish to monitor this application through the EPO registration system.
Archived snapshot
Apr 22, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
COMPOSITIONS AND METHODS FOR TREATING ACNE
Publication EP3458079A1 Kind: A1 Apr 15, 2026
Applicants
Regents of the University of California, University of Pittsburgh - Of the Commonwealth
System of Higher Education
Inventors
MODLIN, Robert, L., MILLER, Jeffery, F., MARINELLI, Laura, J., HATFULL, Graham, F.
IPC Classifications
A61K 35/76 20150101AFI20200124BHEP C12N 7/00 20060101ALI20200124BHEP A61P 17/10 20060101ALI20200124BHEP
Designated States
AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR
Parties
Related changes
Get daily alerts for EPO Patent Bulletin - Therapeutics (A61P)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from EPO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when EPO Patent Bulletin - Therapeutics (A61P) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.